Medicare Procedure and Patient Information
Conditions of Medicare patients treated by Dr. Sharareh Moraveji, MD in 2019
The most common conditions of Medicare patients that Dr. Sharareh Moraveji, MD treated during 2019 were hypertension.
75 | |
(No ratings)
Dr. Sharareh Moraveji, MD is a gastroenterologist in Fremont, CA specializing in adult gastroenterology. She graduated from Ross University School of Medicine. Dr. Sharareh Moraveji, MD is affiliated with Physicians Medical Group of San Jose, Washington Hospital Healthcare System, Hill Physicians and CALIFORNIA CARDIOVASCULAR CONSULTANTS.
2000 Mowry Avenue
Fremont, CA 94538
2333 Mowry Avenue #300
Fremont 94538
2333 Mowry Avenue Suite 300
Fremont, CA 94538
300 Pasteur Drive
Stanford, CA 94305
500 E Calaveras Boulevard #100
Milpitas 95035
The most common conditions of Medicare patients that Dr. Sharareh Moraveji, MD treated during 2019 were hypertension.
Hypertension | 75 |
---|---|
High Cholesterol | 0 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
The top procedures that Dr. Sharareh Moraveji, MD treated as a gastroenterologist in Fremont, CA during 2020 were hospital care, inpatient care, and .
Volume of procedures performed by Dr. Sharareh Moraveji, MD for Medicare patients.
hospital care | 55 |
---|---|
inpatient care | 55 |
Information about Medicare patients treated by Dr. Sharareh Moraveji, MD.
Male | 18 |
---|---|
Female | 23 |
Non-Hispanic White | 13 |
---|---|
Black | 0 |
Hispanic | 0 |
Asian | 17 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 13 |
---|---|
From 75 to 84 | 15 |
85 and over | 0 |
Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Sharareh Moraveji, MD treated during 2020 were high cholesterol, hypertension, diabetes and chronic kidney disease.
Hypertension | 75 |
---|---|
High Cholesterol | 75 |
Stroke | 0 |
Ischemic Heart Disease | 61 |
Depression | 37 |
Chronic Kidney Disease | 63 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 49 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 68 |
Dementia | 32 |
Cancer | 0 |
The top procedures that Dr. Sharareh Moraveji, MD treated as a gastroenterologist in Fremont, CA during 2021 were hospital care, inpatient care, minimally invasive procedures and gastrointestinal procedures.
Volume of procedures performed by Dr. Sharareh Moraveji, MD for Medicare patients.
blood draw | 43 |
---|---|
diagnostic procedures | 70 |
doctor visit | 263 |
gastrointestinal procedures | 126 |
hospital care | 952 |
inpatient care | 952 |
lab tests | 60 |
minimally invasive procedures | 126 |
preventive care | 25 |
removal of lesion (e.g. growth) | 70 |
Volume of procedures performed by Dr. Sharareh Moraveji, MD for Medicare patients.
The highest averages for the top procedures that Dr. Sharareh Moraveji, MD treated as a gastroenterologist in Fremont, CA were hospital care, inpatient care, minimally invasive procedures and gastrointestinal procedures.
blood draw | 43 |
---|---|
diagnostic procedures | 70 |
doctor visit | 263 |
gastrointestinal procedures | 126 |
hospital care | 503 |
inpatient care | 503 |
lab tests | 60 |
minimally invasive procedures | 126 |
preventive care | 25 |
removal of lesion (e.g. growth) | 70 |
Information about Medicare patients treated by Dr. Sharareh Moraveji, MD.
Male | 2 |
---|---|
Female | 2 |
Black / African American | 0 |
---|---|
Asian / Pacific Islander | 1 |
Non-Hispanic White | 1 |
Hispanic | 0 |
Native American / Alaskan Native | 0 |
Other | 0 |
75 to 84 | 1 |
---|---|
85 and over | 0 |
Less than 65 | 0 |
65 to 74 | 1 |
The highest averages of the most common conditions of Medicare patients that Dr. Sharareh Moraveji, MD treated were hypertension, high cholesterol, chronic kidney disease and diabetes.
Hypertension | 16 |
---|---|
High Cholesterol | 8 |
Stroke | 0 |
Ischemic Heart Disease | 6 |
Depression | 4 |
Chronic Kidney Disease | 7 |
Asthma | 0 |
Osteoporosis | 0 |
Heart Failure | 5 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 7 |
Atrial Fibrillation | 0 |
Cancer | 0 |
Dementia | 3 |
Dr. Sharareh Moraveji, MD graduated from Ross University School of Medicine. She completed residency at Texas Tech University Health Sciences Center. She is certified by the American Board of Internal Medicine - Internal Medicine and has a state license in California.
Medical School: Ross University School of Medicine
Residency: Texas Tech University Health Sciences Center
Board Certification: American Board of Internal Medicine - Internal Medicine
Licensed In: California
Dr. Sharareh Moraveji, MD is associated with these hospitals and organizations:
Dr. Sharareh Moraveji, MD does not have any reviews yet, be the first to leave a review of Dr. Sharareh Moraveji, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Sharareh Moraveji, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Olympus Corporation of the Americas |
$1,404
EndoCapsule $1,404 |
|||||
---|---|---|---|---|---|---|
Boston Scientific Corporation |
$533
GENERAL - THERAPIES $490 |
GENERAL - HEMOSTASIS $43 |
||||
Merck Sharp & Dohme Corporation |
$305
ZEPATIER $184 |
ZERBAXA $121 |
||||
E.R. Squibb & Sons, L.L.C. |
$291
ELIQUIS $291 |
|||||
Pfizer Inc. |
$149
ELIQUIS $149 |
|||||
Other |
$1,092
XTANDI $125 |
Mavyret $119 |
XIFAXAN $118 |
Repatha $117 |
Ocaliva $117 |
Other $496 |
Food and Beverage | $2,205 |
---|---|
Travel and Lodging | $1,568 |
Dr. Sharareh Moraveji's specialty is adult gastroenterology. Her hospital/clinic affiliations include Washington Hospital Healthcare System, Physicians Medical Group of San Jose, and Hill Physicians. Dr. Moraveji attended medical school at Ross University School of Medicine. She trained at Texas Tech University Health Sciences Center for residency. Dr. Moraveji (or staff) speaks the following languages: Spanish and Persian.